BENEPALI 50 mg, solution for injection in a pre-filled pen syringe, 1 ml
Active ingredients: Etanercept
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BENEPALI 50 mg, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre dans stylo pré-rempli de 1 ml
- Marketing authorisation holder
- SAMSUNG BIOEPIS NL (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Psoriasis en plaques sévère chronique (enfant à partir de 6 ans, adolescent et adulte)<br>- Certaines formes de polyarthrite rhumatoïde active (adulte)<br>- Rhumatisme psoriasique actif et évolutif (adulte)<br>- Spondylarthrite ankylosante sévère et active (adulte) ; JOURNAL OFFICIEL ; 21/07/09
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Oct 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69653644CIP73004460CIP133400930044605Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTANERCEPTsolution | 50 mg · un stylo prérempli | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.